(Q35561522)

8 August 2017

1 reference

title

Gender differences in bipolar disorder (English)

1 reference

8 August 2017

1 reference

1

Lesley M Arnold

1 reference

8 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14563100

22 March 2024

publication date

1 September 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S0193953X03000364?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(03)00036-4

https://api.elsevier.com/content/article/PII:S0193953X03000364?httpAccept=text/plain

22 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(03)00036-4

Psychiatric Clinics of North America

22 March 2024

published in

1 reference

8 August 2017

volume

26

1 reference

8 August 2017

issue

3

1 reference

8 August 2017

page(s)

595-620

1 reference

Gender differences in patients with bipolar disorder influence outcome in the medical outcomes survey (SF-20) subscale scores.

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Response to lithium maintenance treatment in bipolar disorders: comparison of women and men

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Seasonal Mood Disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Seasons and bipolar disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Women with bipolar illness: clinical and research issues

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

The course of affective disorders. II. Typology of bipolar manic-depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

The relative prophylactic efficacy of lithium against manic and depressive recurrences in bipolar patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Manic-depressive (bipolar) disorder: the course in light of a prospective ten-year follow-up of 131 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Gender and bipolar illness

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Rapidly cycling affective disorder. Demographics, diagnosis, family history, and course

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Course of the Manic-Depressive Cycle and Changes Caused by Treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Multisite data reanalysis of the validity of rapid cycling as a course modifier for bipolar disorder in DSM-IV.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Validity of rapid cycling as a course specifier for bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

The phenomenon of rapid cycling in bipolar mood disorders: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Lithium maintenance treatment of depression and mania in bipolar I and bipolar II disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Effects of rapid cycling on response to lithium maintenance treatment in 360 bipolar I and II disorder patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Rapid Cycling in Manic-Depressives Induced by Tricyclic Antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Can antidepressants cause mania and worsen the course of affective illness?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Clinical Factors in Lithium Carbonate Prophylaxis Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Rapid cycling manic depressive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Clinical aspects and treatment of rapid cycling mood disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Effects of carbamazepine and lithium on affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Current research on rapid cycling bipolar disorder and its treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

The efficacy of lamotrigine in rapid cycling and non–rapid cycling patients with bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Treatment of Refractory Rapid Cycling Bipolar Disorder With Risperidone

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Quetiapine in the treatment of rapid cycling bipolar disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cycling

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Abnormal cortisol suppression in bipolar patients with simultaneous manic and depressive symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Diagnosis and treatment of mixed mania.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

The role of gender in mixed mania

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

The clinical epidemiology of pure and mixed manic episodes

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

The dexamethasone suppression test in mixed bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Hypothalamic-pituitary-adrenocortical function in mixed and pure mania

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

CSF biochemical correlates of mixed affective states

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Dysphoric mania. Clinical and biological correlates.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Outcome and comorbidity in first- compared with multiple-episode mania

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Twelve-month outcome after a first hospitalization for affective psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Incidence and significance of mixed affective states in a bipolar population

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Demographic and clinical features predictive of recovery in acute mania

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Mania. Diagnosis, state measurement and prediction of treatment response

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Treatment of mixed mania.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

A double-blind comparison of valproate and lithium in the treatment of acute mania

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Depression during mania. Treatment response to lithium or divalproex.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Correlates of antimanic response to carbamazepine

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Use of olanzapine in dysphoric mania

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Treatment of bipolar I rapid cycling patients during dysphoric mania with olanzapine

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Clozapine in the treatment of dysphoric mania

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Complicated mania. Comorbidity and immediate outcome in the treatment of mania.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Comorbidity in mania at first hospitalization

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Prevalence of overweight and obesity in bipolar patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

The effect of lithium treatment on thyroid function in patients with primary affective disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Thyroid abnormalities associated with rapid-cycling bipolar illness

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Rapid cycling bipolar affective disorder. I. Association with grade I hypothyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

The spectrum of thyroid disease in a community: the Whickham survey

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

A family study of rapid-cycling bipolar illness.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Rapid cycling bipolar affective disorder. II. Treatment of refractory rapid cycling with high-dose levothyroxine: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

The thyroid and mixed affective states

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Thyroid function tests in first-episode bipolar disorder manic and mixed types

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Differences in thyroid function between bipolar manic and mixed states.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Thyroid function in mixed and pure manic episodes

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Migraine prophylaxis with divalproex

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Clinical correlates of therapeutic response in bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Correlates of overweight and obesity in 644 patients with bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Substance abuse in bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Substance abuse and bipolar affective disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Alcohol problems and long-term psychosocial outcome in Chinese patients with bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Axis I comorbidity in bipolar disorder with psychotic features

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

A history of substance abuse complicates remission from acute mania in bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Characterizing female bipolar alcoholic patients presenting for initial evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

The emerging epidemiology of hypomania and bipolar II disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Comorbidity of panic disorder in bipolar illness: evidence from the Epidemiologic Catchment Area Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Anxious-bipolar comorbidity. Diagnostic and treatment challenges

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Panic disorder in subjects with pure mania and depressive mania

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Panic disorder with familial bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Comorbid bipolar disorder and panic disorder in families with a high prevalence of bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Gabapentin as a potential treatment for anxiety disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Bipolar II illness: course and outcome over a five-year period.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Lithium treatment and risk of suicidal behavior in bipolar disorder patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Bipolar II disorder and suicidal behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Suicidality in patients with pure and depressive mania

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Suicidality among patients with mixed and manic bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Gender Differences in Bipolar II and Unipolar Depressed Outpatients: A 557-Case Study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Long-term clinical effectiveness of lithium maintenance treatment in types I and II bipolar disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Divalproex therapy in medication-naive and mood-stabilizer-naive bipolar II depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Efficacy and safety of fluoxetine in treating bipolar II major depressive episode.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Tranylcypromine versus imipramine in anergic bipolar depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Venlafaxine monotherapy in women with bipolar II and unipolar major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Bipolar depression: pharmacotherapy and related therapeutic strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Course of illness and pattern of recurrences in patients with affective disorders during long-term lithium prophylaxis: a retrospective analysis over 15 years.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Effectiveness of restarting lithium treatment after its discontinuation in bipolar I and bipolar II disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Sex differences in response to lithium treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Clinically significant pharmacokinetic drug interactions with carbamazepine. An update

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Clinical pharmacokinetics of newer antiepileptic drugs. Lamotrigine, vigabatrin, gabapentin and oxcarbazepine

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Gabapentin does not interact with a contraceptive regimen of norethindrone acetate and ethinyl estradiol

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Obesity and endocrine disorders in women taking valproate for epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Valproate and polycystic ovaries

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Failure of progesterone treatment in puerperal mania

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Course of psychiatric disorders across the menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Premenstrual changes: A comparison of five populations

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Menstrual problems in women with primary affective illness

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Lack of relationship between menstrual cycle phase and mood in a sample of women with rapid cycling bipolar disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

1 reference

7 January 2021

Paroxetine-induced mania

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Treatment of premenstrual tension with lithium carbonate. A pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Effects of the Rate of Discontinuing Lithium Maintenance Treatment in Bipolar Disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Reduced morbidity after gradual discontinuation of lithium treatment for bipolar I and II disorders: a replication study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Recurrence risk in bipolar manic-depressive disorders after discontinuing lithium maintenance treatment: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Discontinuing antidepressant treatment in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Spina bifida in infants of women treated with carbamazepine during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Teratogen update: valproic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Multi-institutional study on the teratogenicity and fetal toxicity of antiepileptic drugs: a report of a collaborative study group in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Maternal valproic acid and congenital neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Pattern of malformations in the children of women treated with carbamazepine during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Lithium and the placenta

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

What happened later to the lithium babies? A follow-up study of children born without malformations.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Clozapine and lorazepam administration in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Clozapine use in two full-term pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Clozapine concentrations in maternal and fetal plasma, amniotic fluid, and breast milk

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Pregnancy and clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Pregnancy of a patient treated with clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Does puerperal illness distinguish a subgroup of bipolar patients?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Male and female mania

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

The impact of reproductive events on the course of bipolar disorder in women

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Postpartum prophylaxis for women with bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Prophylactic lithium in puerperal psychosis. The experience of three centres

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Puerperal affective psychosis: is there a case for lithium prophylaxis?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Epidemiology of puerperal psychoses

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

First admission with puerperal psychosis: 7?14 years of follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Familiality of the puerperal trigger in bipolar disorder: results of a family study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Variation at the serotonin transporter gene influences susceptibility to bipolar affective puerperal psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Serum concentrations of antidepressants and benzodiazepines in nursing infants: A case series.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Antidepressant treatment during breast-feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Lithium and pregnancy. 3. Lithium ingestion by children breast-fed by women on lithium treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Lithium carbonate and breast-feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Toxic effects of lithium in newborn infants: A commentary

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Serum levels of valproate and carbamazepine in breastfeeding mother-infant pairs

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Transient cholestatic hepatitis in a neonate associated with carbamazepine exposure during pregnancy and breast-feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Transient hepatic dysfunction in an infant of an epileptic mother treated with carbamazepine during pregnancy and breastfeeding

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Lamotrigine in pregnancy and lactation: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Sex differences in bipolar affective disorder: neuroleptic dosage variance

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900036-4

7 January 2021

Issues in the treatment of women with bipolar illness

1

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(03)00036-4

Depressive mania associated with nonresponse to antimanic agents

22 March 2024

56

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(03)00036-4

Comorbidity of migraine and major affective disorders

22 March 2024

82

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(03)00036-4

The relationship between substance abuse and bipolar disorder

22 March 2024

99

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(03)00036-4

Panic disorder: treatment with valproate

22 March 2024

107

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(03)00036-4

Lithium side-effects and predictors of hypothyroidism in patients with bipolar disorder: sex differences

22 March 2024

130

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(03)00036-4

A case of rapid mood cycling with estrogen: implications for therapy

22 March 2024

143

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(03)00036-4

Premenstrual tension syndrome in rapid-cycling bipolar affective disorder

22 March 2024

147

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(03)00036-4

Premenstrual tension syndrome in rapid-cycling bipolar affective disorder

22 March 2024

150

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(03)00036-4

The association between premenstrual dysphoric disorder and other mood disorders

22 March 2024

154

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(03)00036-4

The course and management of bipolar disorder during pregnancy

22 March 2024

160

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(03)00036-4

Malformations in offspring of 305 epileptic women: a prospective study

22 March 2024

174

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(03)00036-4

Major and minor birth malformations and antiepileptic drugs

22 March 2024

175

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(03)00036-4

Minor anomalies in children of mothers with epilepsy

22 March 2024

182

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(03)00036-4

22 March 2024

Identifiers

1 reference

release_eg5dpa6sffdq7maryh4gz3rr4e

8 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/eg5dpa6sffdq7maryh4gz3rr4e

24 November 2022

mapped directly with Wikidata item

1 reference